Talphera, Inc. ( (TLPH) ) has released its Q3 earnings. Here is a breakdown of the information Talphera, Inc. presented to its investors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Talphera, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative therapies for medically supervised settings, with a notable emphasis on its lead product candidate, Niyad, which is under investigation as an anticoagulant for extracorporeal circuits.